Large-scale testing (Phase 3)Study completedNCT02546323
What this trial is testing
A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis
Who this might be right for
Atherosclerosis
AstraZeneca 543